Evolus Says Launch of Its Botox Rival Ahead of Its Expectations Evolus Says Launch of Its Botox Rival Ahead of Its Expectations

Evolus Inc on Monday reported revenue of $2.3 million from early sales of its newly launched rival to Allergan Plc ' s Botox, ahead of its own expectations.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Plastic Surgery & Aesthetic Medicine News Source Type: news